-
1
-
-
74349092805
-
Mechanisms of T-cell inhibition: Implications for cancer immunotherapy
-
Mittendorf, E. A. , and P. Sharma. 2010. Mechanisms of T-cell inhibition: implications for cancer immunotherapy. Expert Rev. Vaccines 9: 89-105.
-
(2010)
Expert Rev. Vaccines
, vol.9
, pp. 89-105
-
-
Mittendorf, E.A.1
Sharma, P.2
-
2
-
-
0141720783
-
Cancer vaccines: Between the idea and the reality
-
Finn, O. J. 2003. Cancer vaccines: between the idea and the reality. Nat. Rev. Immunol. 3: 630-641.
-
(2003)
Nat. Rev. Immunol
, vol.3
, pp. 630-641
-
-
Finn, O.J.1
-
3
-
-
79959541203
-
Tumor cell programmed death ligand 1-mediated T cell suppression is overcome by coexpression of CD80
-
Haile, S. T. , J. J. Bosch, N. I. Agu, A. M. Zeender, P. Somasundaram, M. K. Srivastava, S. Britting, J. B. Wolf, B. R. Ksander, and S. Ostrand-Rosenberg. 2011. Tumor cell programmed death ligand 1-mediated T cell suppression is overcome by coexpression of CD80. J. Immunol. 186: 6822-6829.
-
(2011)
J. Immunol
, Issue.186
, pp. 6822-6829
-
-
Haile, S.T.1
Bosch, J.J.2
Agu, N.I.3
Zeender, A.M.4
Somasundaram, P.5
Srivastava, M.K.6
Britting, S.7
Wolf, J.B.8
Ksander, B.R.9
Ostrand-Rosenberg, S.10
-
4
-
-
84855338629
-
Regulatory T cells in melanoma: The final hurdle towards effective immunotherapy?
-
Jacobs, J. F. , S. Nierkens, C. G. Figdor, I. J. de Vries, and G. J. Adema. 2012. Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy? Lancet Oncol. 13: e32-e42.
-
(2012)
Lancet Oncol
, Issue.13
-
-
Jacobs, J.F.1
Nierkens, S.2
Figdor, C.G.3
De Vries, I.J.4
Adema, G.J.5
-
5
-
-
84862143053
-
Melanoma-induced immunosuppression and its neutralization
-
Umansky, V. , and A. Sevko. 2012. Melanoma-induced immunosuppression and its neutralization. Semin. Cancer Biol. 22: 319-326.
-
(2012)
Semin. Cancer Biol
, Issue.22
, pp. 319-326
-
-
Umansky, V.1
Sevko, A.2
-
6
-
-
84872490374
-
Increased prevalence of tumor-infiltrating regulatory T cells is closely related to their lower sensitivity to H2O2-induced apoptosis in gastric and esophageal cancer
-
Izawa, S. , K. Mimura, M. Watanabe, T. Maruyama, Y. Kawaguchi, H. Fujii, and K. Kono. 2013. Increased prevalence of tumor-infiltrating regulatory T cells is closely related to their lower sensitivity to H2O2-induced apoptosis in gastric and esophageal cancer. Cancer Immunol. Immunother. 62: 161-170.
-
(2013)
Cancer Immunol. Immunother
, Issue.62
, pp. 161-170
-
-
Izawa, S.1
Mimura, K.2
Watanabe, M.3
Maruyama, T.4
Kawaguchi, Y.5
Fujii, H.6
Kono, K.7
-
7
-
-
84886943622
-
Re-orienting the immune system: Durable tumor regression and successful re-induction therapy using anti-PD1 antibodies
-
Lipson, E. J. 2013. Re-orienting the immune system: Durable tumor regression and successful re-induction therapy using anti-PD1 antibodies. OncoImmunology 2: e23661.
-
(2013)
OncoImmunology
, vol.2
-
-
Lipson, E.J.1
-
8
-
-
84858766182
-
The blockade of immune checkpoints in cancer immunotherapy
-
Pardoll, D. M. 2012. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12: 252-264.
-
(2012)
Nat. Rev. Cancer
, vol.12
, pp. 252-264
-
-
Pardoll, D.M.1
-
9
-
-
84874255652
-
Immunomodulatory therapy for melanoma: Ipilimumab and beyond
-
Callahan, M. K. , M. A. Postow, and J. D. Wolchok. 2013. Immunomodulatory therapy for melanoma: ipilimumab and beyond. Clin. Dermatol. 31: 191-199.
-
(2013)
Clin. Dermatol
, Issue.31
, pp. 191-199
-
-
Callahan, M.K.1
Postow, M.A.2
Wolchok, J.D.3
-
10
-
-
84879104519
-
Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors
-
Duraiswamy, J. , K. M. Kaluza, G. J. Freeman, and G. Coukos. 2013. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors. Cancer Res. 73: 3591-3603.
-
(2013)
Cancer Res
, Issue.73
, pp. 3591-3603
-
-
Duraiswamy, J.1
Kaluza, K.M.2
Freeman, G.J.3
Coukos, G.4
-
11
-
-
84879579673
-
At the bench: Preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy
-
Intlekofer, A. M. , and C. B. Thompson. 2013. At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy. J. Leukoc. Biol. 94: 25-39.
-
(2013)
J. Leukoc. Biol
, Issue.94
, pp. 25-39
-
-
Intlekofer, A.M.1
Thompson, C.B.2
-
12
-
-
0030793175
-
Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry
-
Whitbeck, J. C. , C. Peng, H. Lou, R. Xu, S. H. Willis, M. Ponce de Leon, T. Peng, A. V. Nicola, R. I. Montgomery, M. S. Warner, et al. 1997. Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry. J. Virol. 71: 6083-6093.
-
(1997)
J. Virol
, vol.71
, pp. 6083-6093
-
-
Whitbeck, J.C.1
Peng, C.2
Lou, H.3
Xu, R.4
Willis, S.H.5
De Leon, M.P.6
Peng, T.7
Nicola, A.V.8
Montgomery, R.I.9
Warner, M.S.10
-
13
-
-
80054850189
-
The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation
-
Steinberg, M. W. , T. C. Cheung, and C. F. Ware. 2011. The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation. Immunol. Rev. 244: 169-187.
-
(2011)
Immunol. Rev
, Issue.244
, pp. 169-187
-
-
Steinberg, M.W.1
Cheung, T.C.2
Ware, C.F.3
-
14
-
-
65349084376
-
The CD160, BTLA, LIGHT/HVEM pathway: A bidirectional switch regulating T-cell activation
-
Cai, G. , and G. J. Freeman. 2009. The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation. Immunol. Rev. 229: 244-258.
-
(2009)
Immunol. Rev
, vol.229
, pp. 244-258
-
-
Cai, G.1
Freeman, G.J.2
-
15
-
-
78049522560
-
Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competition
-
Stiles, K. M. , J. C. Whitbeck, H. Lou, G. H. Cohen, R. J. Eisenberg, and C. Krummenacher. 2010. Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competition. J. Virol. 84: 11646-11660.
-
(2010)
J. Virol
, Issue.84
, pp. 11646-11660
-
-
Stiles, K.M.1
Whitbeck, J.C.2
Lou, H.3
Cohen, G.H.4
Eisenberg, R.J.5
Krummenacher, C.6
-
16
-
-
38949214015
-
Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses
-
Lasaro, M. O. , N. Tatsis, S. E. Hensley, J. C. Whitbeck, S. -W. Lin, J. J. Rux, E. J. Wherry, G. H. Cohen, R. J. Eisenberg, and H. C. Ertl. 2008. Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses. Nat. Med. 14: 205-212.
-
(2008)
Nat. Med
, vol.14
, pp. 205-212
-
-
Lasaro, M.O.1
Tatsis, N.2
Hensley, S.E.3
Whitbeck, J.C.4
Lin, W.S.5
Rux, J.J.6
Wherry, E.J.7
Cohen, G.H.8
Eisenberg, R.J.9
Ertl, H.C.10
-
17
-
-
77954695243
-
Augmentation of primary influenza A virus-specific CD8+ T cell responses in aged mice through blockade of an immunoinhibitory pathway
-
DiMenna, L. , B. Latimer, E. Parzych, L. H. Haut, K. Töpfer, S. Abdulla, H. Yu, B. Manson, W. Giles-Davis, D. Zhou, et al. 2010. Augmentation of primary influenza A virus-specific CD8+ T cell responses in aged mice through blockade of an immunoinhibitory pathway. J. Immunol. 184: 5475-5484.
-
(2010)
J. Immunol
, Issue.184
, pp. 5475-5484
-
-
Dimenna, L.1
Latimer, B.2
Parzych, E.3
Haut, L.H.4
Töpfer, K.5
Abdulla, S.6
Yu, H.7
Manson, B.8
Giles-Davis, W.9
Zhou, D.10
-
18
-
-
80052414652
-
Active immunotherapy combined with blockade of a coinhibitory pathway achieves regression of large tumor masses in cancer-prone mice
-
Lasaro, M. O. , M. Sazanovich, W. Giles-Davis, P. Mrass, R. M. Bunte, D. A. Sewell, S. F. Hussain, Y. -X. Fu, W. Weninger, Y. Paterson, and H. C. Ertl. 2011. Active immunotherapy combined with blockade of a coinhibitory pathway achieves regression of large tumor masses in cancer-prone mice. Mol. Ther. 19: 1727-1736.
-
(2011)
Mol. Ther
, Issue.19
, pp. 1727-1736
-
-
Lasaro, M.O.1
Sazanovich, M.2
Giles-Davis, W.3
Mrass, P.4
Bunte, R.M.5
Sewell, D.A.6
Hussain, S.F.7
Fu, X.Y.8
Weninger, W.9
Paterson, Y.10
Ertl, H.C.11
-
19
-
-
0028208970
-
TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino-but not carboxyl-terminus of the peptide
-
Bacik, I. , J. H. Cox, R. Anderson, J. W. Yewdell, and J. R. Bennink. 1994. TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino-but not carboxyl-terminus of the peptide. J. Immunol. 152: 381-387.
-
(1994)
J. Immunol
, vol.152
, pp. 381-387
-
-
Bacik, I.1
Cox, J.H.2
Anderson, R.3
Yewdell, J.W.4
Bennink, J.R.5
-
20
-
-
34447120664
-
Elevated frequencies of self-reactive CD8+ T cells following immunization with a xenoantigen are due to the presence of a heteroclitic CD4+ T-cell helper epitope
-
Kianizad, K. , L. A. Marshall, N. Grinshtein, D. Bernard, R. Margl, S. Cheng, F. Beermann, Y. Wan, and J. Bramson. 2007. Elevated frequencies of self-reactive CD8+ T cells following immunization with a xenoantigen are due to the presence of a heteroclitic CD4+ T-cell helper epitope. Cancer Res. 67: 6459-6467.
-
(2007)
Cancer Res
, vol.67
, pp. 6459-6467
-
-
Kianizad, K.1
Marshall, L.A.2
Grinshtein, N.3
Bernard, D.4
Margl, R.5
Cheng, S.6
Beermann, F.7
Wan, Y.8
Bramson, J.9
-
21
-
-
0028675323
-
Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides
-
Alexander, J. , J. Sidney, S. Southwood, J. Ruppert, C. Oseroff, A. Maewal, K. Snoke, H. M. Serra, R. T. Kubo, A. Sette, et al. 1994. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity 1: 751-761.
-
(1994)
Immunity
, vol.1
, pp. 751-761
-
-
Alexander, J.1
Sidney, J.2
Southwood, S.3
Ruppert, J.4
Oseroff, C.5
Maewal, A.6
Snoke, K.7
Serra, H.M.8
Kubo, R.T.9
Sette, A.10
-
22
-
-
33646396792
-
Optimization of a self antigen for presentation of multiple epitopes in cancer immunity
-
Guevara-Patino, J. A. , M. E. Engelhorn, M. J. Turk, C. Liu, F. Duan, G. Rizzuto, A. D. Cohen, T. Merghoub, J. D. Wolchok, and A. N. Houghton. 2006. Optimization of a self antigen for presentation of multiple epitopes in cancer immunity. J. Clin. Invest. 116: 1382-1390.
-
(2006)
J. Clin. Invest
, vol.116
, pp. 1382-1390
-
-
Guevara-Patino, J.A.1
Engelhorn, M.E.2
Turk, M.J.3
Liu, C.4
Duan, F.5
Rizzuto, G.6
Cohen, A.D.7
Merghoub, T.8
Wolchok, J.D.9
Houghton, A.N.10
-
23
-
-
0030587918
-
Flanking residues alter antigenicity and immunogenicity of multi-unit CTL epitopes
-
Bergmann, C. C. , Q. Yao, C. K. Ho, and S. L. Buckwold. 1996. Flanking residues alter antigenicity and immunogenicity of multi-unit CTL epitopes. J. Immunol. 157: 3242-3249.
-
(1996)
J. Immunol
, vol.157
, pp. 3242-3249
-
-
Bergmann, C.C.1
Yao, Q.2
Ho, C.K.3
Buckwold, S.L.4
-
24
-
-
0025900181
-
Efficient processing of an antigenic sequence for presentation by MHC class i molecules depends on its neighboring residues in the protein
-
Del Val, M. , H. -J. Schlicht, T. Ruppert, M. J. Reddehase, and U. H. Koszinowski. 1991. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66: 1145-1153.
-
(1991)
Cell
, vol.66
, pp. 1145-1153
-
-
Del Val, M.1
Schlicht, J.H.2
Ruppert, T.3
Reddehase, M.J.4
Koszinowski, U.H.5
-
25
-
-
78049414350
-
An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector
-
Zhou, D. , X. Zhou, A. Bian, H. Li, H. Chen, J. C. Small, Y. Li, W. Giles-Davis, Z. Xiang, and H. C. J. Ertl. 2010. An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector. Nat. Protoc. 5: 1775-1785.
-
(2010)
Nat. Protoc
, Issue.5
, pp. 1775-1785
-
-
Zhou, D.1
Zhou, X.2
Bian, A.3
Li, H.4
Chen, H.5
Small, J.C.6
Li, Y.7
Giles-Davis, W.8
Xiang, Z.9
Ertl, H.C.J.10
-
26
-
-
0037383592
-
Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment
-
Wherry, E. J. , J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77: 4911-4927.
-
(2003)
J. Virol
, vol.77
, pp. 4911-4927
-
-
Wherry, E.J.1
Blattman, J.N.2
Murali-Krishna, K.3
Most Der R.Van4
Ahmed, R.5
-
27
-
-
79956077563
-
T cell exhaustion
-
Wherry, E. J. 2011. T cell exhaustion. Nat. Immunol. 12: 492-499.
-
(2011)
Nat. Immunol
, Issue.12
, pp. 492-499
-
-
Wherry, E.J.1
-
28
-
-
65349104572
-
Mechanisms of costimulation
-
Sharpe, A. H. 2009. Mechanisms of costimulation. Immunol. Rev. 229: 5-11.
-
(2009)
Immunol. Rev
, vol.229
, pp. 5-11
-
-
Sharpe, A.H.1
-
29
-
-
84878648470
-
The nature of activatory and tolerogenic dendritic cellderived signal II
-
de Vries, I. J. M. 2013. The nature of activatory and tolerogenic dendritic cellderived signal II. Front. Immunol. 4 53
-
(2013)
Front. Immunol
, vol.4
, pp. 53
-
-
De Vries, I.J.M.1
-
30
-
-
2442477456
-
An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection
-
Han, P. , O. D. Goularte, K. Rufner, B. Wilkinson, and J. Kaye. 2004. An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection. J. Immunol. 172: 5931-5939.
-
(2004)
J. Immunol
, vol.172
, pp. 5931-5939
-
-
Han, P.1
Goularte, O.D.2
Rufner, K.3
Wilkinson, B.4
Kaye, J.5
-
31
-
-
65349118810
-
PD-1 signaling in primary T cells
-
Riley, J. L. 2009. PD-1 signaling in primary T cells. Immunol. Rev. 229: 114-125.
-
(2009)
Immunol. Rev
, Issue.229
, pp. 114-125
-
-
Riley, J.L.1
-
32
-
-
27144496045
-
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
-
Parry, R. V. , J. M. Chemnitz, K. A. Frauwirth, A. R. Lanfranco, I. Braunstein, S. V. Kobayashi, P. S. Linsley, C. B. Thompson, and J. L. Riley. 2005. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol. Cell. Biol. 25: 9543-9553.
-
(2005)
Mol. Cell. Biol
, vol.25
, pp. 9543-9553
-
-
Parry, R.V.1
Chemnitz, J.M.2
Frauwirth, K.A.3
Lanfranco, A.R.4
Braunstein, I.5
Kobayashi, S.V.6
Linsley, P.S.7
Thompson, C.B.8
Riley, J.L.9
-
34
-
-
0344495270
-
Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2
-
Gavrieli, M. , N. Watanabe, S. K. Loftin, T. L. Murphy, and K. M. Murphy. 2003. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2. Biochem. Biophys. Res. Commun. 312: 1236-1243.
-
(2003)
Biochem. Biophys. Res. Commun
, vol.312
, pp. 1236-1243
-
-
Gavrieli, M.1
Watanabe, N.2
Loftin, S.K.3
Murphy, T.L.4
Murphy, K.M.5
-
35
-
-
84882455083
-
Genetic risk factors for Clostridium difficile infection in ulcerative colitis
-
Ananthakrishnan, A. N. , E. C. Oxford, D. D. Nguyen, J. Sauk, V. Yajnik, and R. J. Xavier. 2013. Genetic risk factors for Clostridium difficile infection in ulcerative colitis. Aliment Pharmacol. Ther. 38: 522-530.
-
(2013)
Aliment Pharmacol. Ther
, Issue.38
, pp. 522-530
-
-
Ananthakrishnan, A.N.1
Oxford, E.C.2
Nguyen, D.D.3
Sauk, J.4
Yajnik, V.5
Xavier, R.J.6
-
36
-
-
29644440938
-
Haplotype analysis of tumour necrosis factor receptor genes in 1p36: No evidence for association with systemic lupus erythematosus
-
Chadha, S. , K. Miller, L. Farwell, S. Sacks, M. J. Daly, J. D. Rioux, and T. J. Vyse. 2006. Haplotype analysis of tumour necrosis factor receptor genes in 1p36: no evidence for association with systemic lupus erythematosus. Eur. J. Hum. Genet. 14: 69-78.
-
(2006)
Eur. J. Hum. Genet
, vol.14
, pp. 69-78
-
-
Chadha, S.1
Miller, K.2
Farwell, L.3
Sacks, S.4
Daly, M.J.5
Rioux, J.D.6
Vyse, T.J.7
-
37
-
-
1642460185
-
High levels of soluble herpes virus entry mediator in sera of patients with allergic and autoimmune diseases
-
Jung, H. W. , S. J. La, J. Y. Kim, S. K. Heo, J. Y. Kim, S. Wang, K. K. Kim, K. M. Lee, H. R. Cho, H. W. Lee, et al. 2003. High levels of soluble herpes virus entry mediator in sera of patients with allergic and autoimmune diseases. Exp. Mol. Med. 35: 501-508.
-
(2003)
Exp. Mol. Med
, vol.35
, pp. 501-508
-
-
Jung, H.W.1
La, S.J.2
Kim, J.Y.3
Heo, S.K.4
Kim, J.Y.5
Wang, S.6
Kim, K.K.7
Lee, K.M.8
Cho, H.R.9
Lee, H.W.10
-
38
-
-
45149112172
-
A crucial role for HVEM and BTLA in preventing intestinal inflammation
-
Steinberg, M. W. , O. Turovskaya, R. B. Shaikh, G. Kim, D. F. McCole, K. Pfeffer, K. M. Murphy, C. F. Ware, and M. Kronenberg. 2008. A crucial role for HVEM and BTLA in preventing intestinal inflammation. J. Exp. Med. 205: 1463-1476.
-
(2008)
J. Exp. Med
, vol.205
, pp. 1463-1476
-
-
Steinberg, M.W.1
Turovskaya, O.2
Shaikh, R.B.3
Kim, G.4
McCole, D.F.5
Pfeffer, K.6
Murphy, K.M.7
Ware, C.F.8
Kronenberg, M.9
-
39
-
-
80855123469
-
B-and T-lymphocyte attenuator targeting protects against the acute phase of graft versus host reaction by inhibiting donor anti-host cytotoxicity
-
del Rio, M. -L. , J. Kurtz, C. Perez-Martinez, A. Ghosh, J. A. Perez-Simon, and J. -I. Rodriguez-Barbosa. 2011. B-and T-lymphocyte attenuator targeting protects against the acute phase of graft versus host reaction by inhibiting donor anti-host cytotoxicity. Transplantation 92: 1085-1093.
-
(2011)
Transplantation
, vol.92
, pp. 1085-1093
-
-
De Rio, L.M.1
Kurtz, J.2
Perez-Martinez, C.3
Ghosh, A.4
Perez-Simon, J.A.5
Rodriguez-Barbosa, I.J.6
-
40
-
-
0346025546
-
Stimulation of non-Hodgkin's lymphoma via HVEM: An alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity
-
Costello, R. T. , F. Mallet, B. Barbarat, J. -M. Schiano De Colella, D. Sainty, R. W. Sweet, A. Truneh, and D. Olive. 2003. Stimulation of non-Hodgkin's lymphoma via HVEM: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity. Leukemia 17: 2500-2507.
-
(2003)
Leukemia
, vol.17
, pp. 2500-2507
-
-
Costello, R.T.1
Mallet, F.2
Barbarat, B.3
De Colella, J.M.S.4
Sainty, D.5
Sweet, R.W.6
Truneh, A.7
Olive, D.8
-
41
-
-
74949125667
-
BTLA mediates inhibition of human tumorspecific CD8+ T cells that can be partially reversed by vaccination
-
Derré, L. , J. -P. Rivals, C. Jandus, S. Pastor, D. Rimoldi, P. Romero, O. Michielin, D. Olive, and D. E. Speiser. 2010. BTLA mediates inhibition of human tumorspecific CD8+ T cells that can be partially reversed by vaccination. J. Clin. Invest. 120: 157-167.
-
(2010)
J. Clin. Invest
, Issue.120
, pp. 157-167
-
-
Derré, L.1
Rivals, P.J.2
Jandus, C.3
Pastor, S.4
Rimoldi, D.5
Romero, P.6
Michielin, O.7
Olive, D.8
Speiser, D.E.9
-
42
-
-
84863393290
-
CD8+ T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1
-
Fourcade, J. , Z. Sun, O. Pagliano, P. Guillaume, I. F. Luescher, C. Sander, J. M. Kirkwood, D. Olive, V. Kuchroo, and H. M. Zarour. 2012. CD8+ T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1. Cancer Res. 72: 887-896.
-
(2012)
Cancer Res
, Issue.72
, pp. 887-896
-
-
Fourcade, J.1
Sun, Z.2
Pagliano, O.3
Guillaume, P.4
Luescher, I.F.5
Sander, C.6
Kirkwood, J.M.7
Olive, D.8
Kuchroo, V.9
Zarour, H.M.10
-
43
-
-
42049111434
-
Programmed death-1 as a factor in immune exhaustion and activation in HIV infection
-
Kaufmann, D. E. , and B. D. Walker. 2008. Programmed death-1 as a factor in immune exhaustion and activation in HIV infection. Curr. Opin. HIV AIDS 3: 362-367.
-
(2008)
Curr. Opin. HIV AIDS
, vol.3
, pp. 362-367
-
-
Kaufmann, D.E.1
Walker, B.D.2
-
44
-
-
34247612265
-
Flying under the radar: The immunobiology of hepatitis C
-
Dustin, L. B. , and C. M. Rice. 2007. Flying under the radar: the immunobiology of hepatitis C. Annu. Rev. Immunol. 25: 71-99.
-
(2007)
Annu. Rev. Immunol
, vol.25
, pp. 71-99
-
-
Dustin, L.B.1
Rice, C.M.2
-
45
-
-
79957925314
-
Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients
-
Baitsch, L. , P. Baumgaertner, E. Devêvre, S. K. Raghav, A. Legat, L. Barba, S. Wieckowski, H. Bouzourene, B. Deplancke, P. Romero, et al. 2011. Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients. J. Clin. Invest. 121: 2350-2360.
-
(2011)
J. Clin. Invest
, Issue.121
, pp. 2350-2360
-
-
Baitsch, L.1
Baumgaertner, P.2
Devêvre, E.3
Raghav, S.K.4
Legat, A.5
Barba, L.6
Wieckowski, S.7
Bouzourene, H.8
Deplancke, B.9
Romero, P.10
-
46
-
-
77951258833
-
Features of responding T cells in cancer and chronic infection
-
Kim, P. S. , and R. Ahmed. 2010. Features of responding T cells in cancer and chronic infection. Curr. Opin. Immunol. 22: 223-230.
-
(2010)
Curr. Opin. Immunol
, Issue.22
, pp. 223-230
-
-
Kim, P.S.1
Ahmed, R.2
-
47
-
-
57849168934
-
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
-
Blackburn, S. D. , H. Shin, W. N. Haining, T. Zou, C. J. Workman, A. Polley, M. R. Betts, G. J. Freeman, D. A. A. Vignali, and E. J. Wherry. 2009. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10: 29-37.
-
(2009)
Nat. Immunol
, vol.10
, pp. 29-37
-
-
Blackburn, S.D.1
Shin, H.2
Haining, W.N.3
Zou, T.4
Workman, C.J.5
Polley, A.6
Betts, M.R.7
Freeman, G.J.8
Vignali, D.A.A.9
Wherry, E.J.10
-
48
-
-
35349014587
-
Molecular signature of CD8+ T cell exhaustion during chronic viral infection
-
Wherry, E. J. , S. -J. Ha, S. M. Kaech, W. N. Haining, S. Sarkar, V. Kalia, S. Subramaniam, J. N. Blattman, D. L. Barber, and R. Ahmed. 2007. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27: 670-684.
-
(2007)
Immunity
, vol.27
, pp. 670-684
-
-
Wherry, E.J.1
Ha, J.S.2
Kaech, S.M.3
Haining, W.N.4
Sarkar, S.5
Kalia, V.6
Subramaniam, S.7
Blattman, J.N.8
Barber, D.L.9
Ahmed, R.10
-
49
-
-
58149314579
-
NFATc1 regulates PD-1 expression upon T cell activation
-
Oestreich, K. J. , H. Yoon, R. Ahmed, and J. M. Boss. 2008. NFATc1 regulates PD-1 expression upon T cell activation. J. Immunol. 181: 4832-4839.
-
(2008)
J. Immunol
, vol.181
, pp. 4832-4839
-
-
Oestreich, K.J.1
Yoon, H.2
Ahmed, R.3
Boss, J.M.4
-
50
-
-
84874585981
-
SHP-1 phosphatase activity counteracts increased T cell receptor affinity
-
Hebeisen, M. , L. Baitsch, D. Presotto, P. Baumgaertner, P. Romero, O. Michielin, D. E. Speiser, and N. Rufer. 2013. SHP-1 phosphatase activity counteracts increased T cell receptor affinity. J. Clin. Invest. 123: 1044-1056.
-
(2013)
J. Clin. Invest
, Issue.123
, pp. 1044-1056
-
-
Hebeisen, M.1
Baitsch, L.2
Presotto, D.3
Baumgaertner, P.4
Romero, P.5
Michielin, O.6
Speiser, D.E.7
Rufer, N.8
-
51
-
-
84879619273
-
Functional differences between low-and high-affinity CD8+ T cells in the tumor environment
-
Bos, R. , K. L. Marquardt, J. Cheung, and L. A. Sherman. 2012. Functional differences between low-and high-affinity CD8+ T cells in the tumor environment. OncoImmunology 1: 1239-1247.
-
(2012)
OncoImmunology
, vol.1
, pp. 1239-1247
-
-
Bos, R.1
Marquardt, K.L.2
Cheung, J.3
Sherman, L.A.4
|